Gene-Corrected skin cells may offer lasting relief for 'Butterfly Children'
Disease control
ENROLLING_BY_INVITATION
This study follows people with recessive dystrophic epidermolysis bullosa (RDEB), a severe blistering skin disease, who previously received an experimental treatment called EB-101. EB-101 uses gene-corrected skin cells to help wounds heal. Researchers will track wound closure, pa…
Sponsor: Abeona Therapeutics, Inc • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC